Pipeline
Our product pipeline reflects a commitment to developing cutting-edge exosome-based therapies and nanodrugs to address critical medical needs and to improve patient outcomes across various indications.
PROGRAM
ExoPTEN
PNN targeting
sequences (2)
Exosomes and
Stem Cells
INDICATION
Acute Spinal
Cord Injury
Glaucoma
Facial
Several - CNS
Traumatic Injury
Chronic Spinal
Cord Injury
Collaboration with Inteligex leverages their novel targeted human stem cell platform which replaces key cell types lost due to traumatic injury or neurodegeneration